Análisis de las infecciones relacionadas con la atención sanitaria antes y durante la pandemia de COVID-19 en un hospital colombiano

Prevention of Hospital Acquired Infections: A practical Guide, G Ducel, J Gabry, L Nicolle. 2nd edition, 2002, Published by World Health Organization WHO/CDS/CSR/EPH/, Geneva; 2002.

Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, et al. Multistate Point-Prevalence Survey of Health Care–Associated Infections. N Engl J Med. 2014;370(13):1198–208. https://doi.org/10.1056/NEJMoa1306801

Centers for Disease Control and Prevention. National and State Healthcare-associated Infections Progress Report. [Internet] [cited 2016 May 27]. Available from: https://www.cdc.gov/hai/data/portal/progress-report.html

Myny D, Depuydt P, Colardyn F, Blot S. Ventilator-associated pneumonia in a tertiary care ICU: analysis of risk factors for acquisition and mortality. Acta Clin. Belg. 2005;60(3):114–121. https://doi.org/10.1179/acb.2005.022

Guzmán-Herrador B, Molina CD, Allam MF, Navajas RFC. Independent risk factors associated with hospital-acquired pneumonia in an adult ICU: 4-year prospective cohort study in a university reference hospital. J. Public Health (Oxf) 2016;38(2):378–383. https://doi.org/10.1093/pubmed/fdv042

Blot S. Antiseptic mouthwash, the nitrate-nitrite-nitric oxide pathway, and hospital mortality: a hypothesis generating review. Intensive Care Med. 2021;47(1):28–38. https://doi.org/10.1007/s00134-020-06276-z

Otero ML, Menezes RC, Ferreira IBB, Issa FL, Agareno G, Carmo TA, et al. Factors associated with mortality in critically ill patients diagnosed with hospital acquired infections. Infect Drug Resist. 2020;13:2811–7. https://doi.org//10.2147/IDR.S347794

World Health Organization. Guidelines on core components of infection prevention and control programmes at the national and acute health care facility level. World Health Organization. [Internet] 2016 [cited 2022 May 27]. Available from: https://www.who.int/publications/i/item/9789241549929

Allegranzi B, Nejad SB, Combescure C, Graafmans W, Attar H, Donaldson L, et al. Burden of endemic health-care-associated infection in developing countries: Systematic review and meta-analysis. The Lancet. 2011;377(9761). https://doi.org//10.1016/S0140-6736(10)61458-4

Magill SS, Hellinger W, Cohen J, Kay R, Bailey C, Boland B, et al. Prevalence of healthcare-associated infections in acute care hospitals in Jacksonville, Florida. Infect Control Hosp Epidemiol. 2012;33(3):283-91. https://doi.org//10.1086/664048

Instituto Nacional de Salud. Dirección de redes en salud pública. Informe de resultados de la vigilancia por laboratorio de resistencia antimicrobiana en infecciones asociadas a la atención en salud (IAAS 2018) Consulta: agosto 22, 2020. https://www.ins.gov.co/buscador-eventos/Informacin%20de%20laboratorio/Informe-vigilancia-por-laboratorio-resistencia-antimicrobiana-y-whonet-IAAS-2018.pdf

Instituto Nacional de Salud. Dirección de redes en salud pública. Informe de resultados de la vigilancia por laboratorio de resistencia antimicrobiana en infecciones asociadas a la atención en salud (IAAS 2018) Consulta: agosto 22, 2020. https://www.ins.gov.co/buscador-eventos/Informacin%20de%20laboratorio/Informe-vigilancia-por-laboratorio-resistencia-antimicrobiana-y-whonet-IAAS-2018.pdf

Goodman KE, Simner PJ, Tamma PD, Milstone AM. Infection control implications of heterogeneous resistance mechanisms in carbapenem- resistant Enterobacteriaceae (CRE). Expert Rev Anti Infect Ther. 2016;14(1):95-108. https://doi.org/10.1586/14787210.2016.1106940

Canton R, Gijon D, Ruiz-Garbajosa P. Antimicrobial resistance in ICUs: An update in the light of the COVID-19 pandemic. Curr Opin Crit Care. 2020;26(5):433-41. https://doi.org/10.1097/MCC.0000000000000755

Bork JT, Leekha S, Claeys K, Seung H, Tripoli M, Amoroso A, et al. Change in hospital antibiotic use and acquisition of multidrug-resistant gram-negative organisms after the onset of coronavirus disease 2019. Infect Control Hosp Epidemiol. 2021;42(9):1115-7. https://doi.org/10.1017/ice.2020.1360

Garcia-Vidal C, Sanjuan G, Moreno-Garcia E, Puerta-Alcalde P, Garcia-Pouton N, Chumbita M, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. 2021; 27(1):83–88. https://doi.org//10.1016/j.cmi.2020.07.041

Kumar G, Adams A, Hererra M, Rojas ER, Singh V, Sakhuja A, et al. Predictors and outcomes of healthcare-associated infections in COVID-19 patients. Int J Infect Dis. 2021; 104:287–92. https://doi.org//10.1016/j.ijid.2020.11.135

O'Toole RF. The interface between COVID-19 and bacterial healthcare-associated infections. Clin Microbiol Infect. 2021;27(12):1772-1776. https://doi.org/10.1016/j.cmi.2021.06.001

Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309-32. https://doi.org//10.1016/j.ajic.2008.03.002

Lan L, Xu D, Ye G, et al. Positive RT-PCR test results in patients recovered from COVID19. JAMA. 2020;323(15)1502-1503. https://doi.org//10.1001/jama.2020.2783

Stelling JM, O'Brien TF. Surveillance of antimicrobial resistance: the WHONET program. Clinical infectious diseases. 1997;24(1):S157-S68. https://doi.org//10.1093/clinids/24.supplement_1.s157

Wintaco LM, Quintero-Lesmes DC, Vargas JA, Barrera DM, Palacio LN, Granados U, et al. Base Datos IAAS - Analysis Healthcare Infections before and during of COVID-19 pandemic in a Colombian hospital. GitLab 2023. https://gitlab.com/investigaciones1/IAAS

Aranaz-Andrés JM, Aibar-Remón C, Limón-Ramírez R, Amarillac A, Restrepo FR, Urroze O, et al. Diseño del estudio IBEAS: prevalencia de efectos adversos en hospitales de Latinoamérica. Revista de calidad asistencial. 2011;26(3):194-200. https://doi.org//10.1016/j.cali.2010.12.001

Luna CM, Rodriguez-Noriega E, Bavestrello L, Guzmán-Blanco M. Gram-negative infections in adult intensive care units of latin america and the caribbean. Crit Care Res and Pract. 2014;480463. https://doi.org/10.1155/2014/480463

Sikora A, Zahra F. Nosocomial Infections. In: StatPearls. Treasure Island (FL): StatPearls Publishing. [Internet] 2024 [Updated 2023 Apr 27] Available from: https://www.ncbi.nlm.nih.gov/books/NBK559312/.

Subbalakshmi E. Surveillance of Hospital Acquired Infection from Frequently Handled Surfaces in a Tertiary Care Teaching Hospital. Int. J.Curr. Microbiol. 2018;7(2) 860-866. https://doi.org/10.20546/ijcmas.2018.702.108

Cortes JA, Leal AL, Montañez AM, Buitrago G, Castillo JS, Guzman L. Frequency of microorganisms isolated in patients with bacteremia in intensive care units in Colombia and their resistance profiles. Braz J Infect Dis. 2013;17(3):346–52. https://doi.org/10.1016/j.bjid.2012.10.022

Leal AL, Cortés JA, Arias G, Ovalle MV, Saavedra SY, Buitrago G, et al. Emergence of resistance to third generation cephalosporins by Enterobacteriaceae causing community-onset urinary tract infections in hospitals in Colombia]. Enferm Infecc Microbiol Clin. 2013;31(5):298-303. https://doi.org/10.1016/j.eimc.2012.04.007

Stewart S, Robertson C, Kennedy S, Kavanagh K, Haahr L, Manoukian S, et al. Personalized infection prevention and control: identifying patients at risk of healthcare-associated infection. J Hosp Infect. 2021;114:32-42. https://doi.org/10.1016/j.jhin.2021.03.032

Leal AL, Álvarez CA, Cortes J, Camacho G, Sáenz V. Boletín informativo GREBO. [Internet] 2017 [cited 2018 Oct 14]; Available from: www.grupogrebo.org

Sligl WI, Dragan T, Smith SW. Nosocomial Gram-negative bacteremia in intensive care: Epidemiology, antimicrobial susceptibilities, and outcomes. Int J of Infect Dis. 2015; 37:129-34. https://doi.org/10.1016/j.ijid.2015.06.024

Dananché C, Bénet T, Allaouchiche B, Hernu R, Argaud L, Dauwalder O, et al. Targeted screening for third-generation cephalosporin-resistant Enterobacteriaceae carriage among patients admitted to intensive care units: a quasi-experimental study. Crit Care. 2015;19(1):38. https://doi.org/10.1186/s13054-015-0754-7

Langford BJ, Brown KA, Diong C, Marchand-Austin A, Adomako K, Saedi A, et al. The Benefits and Harms of Antibiotic Prophylaxis for Urinary Tract Infection in Older Adults. Clin Infect Dis. 2021;73(3):e782-e791. https://doi.org/10.1093/cid/ciab116

Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: Systematic review and meta-analysis. BMJ. 2010;340:c2096. https://doi.org/10.1136/bmj.c2096

Waller TA, Pantin SAL, Yenior AL, Pujalte GGA. Urinary Tract Infection Antibiotic Resistance in the United States. Prim Care. 2018;45(3):455–66. https://doi.org/10.1016/j.pop.2018.05.005

Gamalathge PU, Kularatna S, Carter HE, Senanayake S, Graves N. Cost-effectiveness of interventions to reduce the risk of healthcare-acquired infections in middle-income countries: A systematic review. J Infect Prev. 2019;20(6):266-273. https://doi.org/10.1177/1757177419852662

Zimlichman E, Henderson D, Tamir O, Franz C, Song P, Yamin CK, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013;173(22):2039-2046. https://doi.org/10.1001/jamainternmed.2013.9763

Voidazan S, Albu S, Toth R, Grigorescu B, Rachita A, Moldovan I. Healthcare Associated Infections-A New Pathology in Medical Practice? Int J Environ Res Public Health. 2020;17(3):760. https://doi.org/10.3390/ijerph17030760

Hurford A, Morris AM, Fisman DN, Wu J. Linking antimicrobial prescribing to antimicrobial resistance in the ICU: Before and after an antimicrobial stewardship program. Epidemics. 2012;4(4):203–10. https://doi.org/10.1016/j.epidem.2012.12.001

Katsios CM, Burry L, Nelson S, Jivraj T, Lapinsky SE, Wax RS, et al. An antimicrobial stewardship program improves antimicrobial treatment by culture site and the quality of antimicrobial prescribing in critically ill patients. Crit Care. 2012;16(6):1-9. https://doi.org/10.1186/cc11854

Comments (0)

No login
gif